Background: There are multiple stroke guidelines globally. To synthesize these and
summarize what existing stroke guidelines recommend about the management of people …

This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …

Objective To identify gaps in national stroke guidelines that could be bridged to enhance the
quality of stroke care services in low-and middle-income countries. Methods We …

Background: In-hospital stroke death rate is an important sanitary issue. Despite advances
in the acute phase management of stroke patients, mortality and disability rates remain high …

Background Recent preclinical studies have shown that regulatory T cells (Treg) play a key
role in the immune response after ischemic stroke (IS). However, the role of Treg in human …

Brain damage, including blood-brain barrier (BBB) dysfunction, neurological behavior
deficit, cerebral infarction and inflammation, is commonly caused by ischemic-reperfusion …

Stroke is a serious health condition that is responsible for more than 5% of total deaths. Near
20% of patients experiencing stroke die every year, resulting in the stroke being at the top of …

Nonarteritic central retinal artery occlusion (NA-CRAO) is a variant of acute ischemic stroke
(AIS) and is a cause of sudden severe loss of vision. There are guidelines by the American …

Background The most characteristic clinical signs of stroke are motor and/or sensory
involvement of one side of the body. Respiratory involvement has also been described …

Purpose Management of stroke secondary to septic emboli (SE) remains challenging, due to
both the lack of specific recommendations and the gravity of the underlying pathology. The …